Avatrombopag maleate, a novel thrombopoietin receptor agonist, has emerged as a promising therapeutic agent for the management of various myeloid disorders. Its mechanism of action involves stimulating platelet https://gregoryfvdf530885.blogdigy.com/avatrombopag-maleate-exploring-its-therapeutic-potential-in-myeloid-disorders-47971118